tirzepatide safe for breastfeeding - Drugs and Lactation Database (LactMed®) Is Tirzepatide Safe While Breastfeeding?

Patients must be clearly informed of the risks associated with nonFDA-approved products, including potential contamination, inaccurate dosing, variable bioactivity, and the presence of impurities that may provoke adverse or unpredictable effects

1,815.07 g/mol Purity 98% CAS No

In clinical studies, patients with T2DM treated with Ozempic or Mounjaro also experienced weight loss

Our team always recommends labeling the vial with a permanent marker, noting the date of reconstitution and the final concentration (e.g., "GHK-Cu 10mg/mL, Recon on 10/26/23")

In the intervention arm, weight loss was greater in the first year than at the end of follow-up (8.6% versus 0.7% in controls at 1 year

Dehydration reduces blood flow to the kidneys, causing a pre-renal acute kidney injury